Guardant Health
GH
#2441
Rank
NZ$10.37 B
Marketcap
$83.96
Share price
2.43%
Change (1 day)
131.87%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

P/S ratio for Guardant Health (GH)

P/S ratio as of February 2025 (TTM): 8.64

According to Guardant Health 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is -99.5. At the end of 2024 the company had a P/S ratio of 4.07.

P/S ratio history for Guardant Health from 2018 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20244.07-30.16%
20235.82-6.07%
20226.20-77.22%
202127.2-39.44%
202044.931.28%
201934.2-3.75%
201835.6

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
15.0 73.16%๐Ÿ‡บ๐Ÿ‡ธ USA
2.31-73.21%๐Ÿ‡บ๐Ÿ‡ธ USA